# FDA Inspection 1013823 - David Leiman - April 21, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/david-leiman/5f3ee30f-57b3-42c3-ab61-fd10c3de0037
Source feed: FDA_Inspections

> FDA Inspection 1013823 for David Leiman on April 21, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1013823
- Company Name: David Leiman
- Inspection Date: 2017-04-21
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1054004 - 2018-05-17](https://www.globalkeysolutions.net/records/fda_inspections/david-leiman/2e4de478-9e12-4046-985a-9b630f1aaa79)
- [FDA Inspection 1044434 - 2017-12-08](https://www.globalkeysolutions.net/records/fda_inspections/david-leiman/ecfc24f7-6818-43f1-9d3f-2f0f5f3dddf0)

Company: https://www.globalkeysolutions.net/companies/david-leiman/6f5c6890-a8eb-4d85-95d6-06e3cc468d69

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c